Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Hematology (Amsterdam, Netherlands)|September 27, 2022
The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors: clinical outcomes and medical encounters from the patient perspectiveFlore Sicre de Fontbrune, Pascale Burmester, Maria Piggin, et al.
Experimental Hematology|September 12, 2022
CXCR4 and CD74 together enhance cell survival in response to macrophage migration-inhibitory factor in chronic lymphocytic leukemiaTharshika Thavayogarajah, Dzmitry Sinitski, Omar El Bounkari, et al.
Human Vaccines & Immunotherapeutics|May 23, 2015
CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myelomaSara Yousef, Magdalena Kovacsovics-Bankowski, Mohamed E Salama, et al.
Future Oncology (London, England)|July 21, 2021
Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinomaMartin Metzenmacher, Filippo Rizzo, Kato Kambartel, et al.
Frontiers in Immunology|May 27, 2024
Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activityTodor Tschongov, Swagata Konwar, Andreas Busch, et al.
Clinical and Translational Allergy|July 3, 2026
A Real-World Cross-Sectional Study on Suspected Mast Cell Activation Syndrome: Multiple Heterogeneous Symptoms IdentifiedAnnika Gutsche, Thomas Buttgereit, Rüdiger Buchkremer, et al.
European Journal of Haematology|June 24, 2022
The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors in France, Germany and the United Kingdom: Patient-reported insights on symptoms and quality of lifeJens Panse, Flore Sicre de Fontbrune, Pascale Burmester, et al.
Investigational New Drugs|March 15, 2012
Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemiasPatrick Ziegler, Tuhama Chahoud, Thomas Wilhelm, et al.
Haematologica|May 25, 2011
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myelomaDjordje Atanackovic, Jens Panse, York Hildebrandt, et al.
Clinical Chemistry|November 10, 2017
Leukocyte Counts Based on DNA Methylation at Individual CytosinesJoana Frobel, Tanja Božić, Michael Lenz, et al.
Pageof 13